[HTML][HTML] COVID-19 and solid organ transplantation: role of anti-SARS-CoV-2 monoclonal antibodies
A Dhand, RR Razonable - Current Transplantation Reports, 2022 - Springer
Abstract Purpose of Review Solid organ transplant recipients (SOTRs) are ideal candidates
for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
A Dhand, RR Razonable - Current transplantation reports, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose of review Solid organ transplant recipients (SOTRs) are ideal candidates for early
treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS-CoV-2 …
treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS-CoV-2 …
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-Cov-2 Monoclonal Antibodies
A Dhand, RR Razonable - 2022 - touroscholar.touro.edu
PURPOSE OF REVIEW: Solid organ transplant recipients (SOTRs) are ideal candidates for
early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
[HTML][HTML] COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
A Dhand, RR Razonable - Current Transplantation Reports, 2022 - ncbi.nlm.nih.gov
Summary Anti-SARS-CoV-2 antibodies are currently authorized for treatment of mild-
moderate COVID-19 and post-exposure prophylaxis, including in SOTRs. Potential future …
moderate COVID-19 and post-exposure prophylaxis, including in SOTRs. Potential future …
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
A Dhand, RR Razonable - Current Transplantation …, 2022 - mayoclinic.elsevierpure.com
Abstract Purpose of Review: Solid organ transplant recipients (SOTRs) are ideal candidates
for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS …
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
A Dhand, RR Razonable - Current Transplantation Reports, 2022 - europepmc.org
Summary Anti-SARS-CoV-2 antibodies are currently authorized for treatment of mild-
moderate COVID-19 and post-exposure prophylaxis, including in SOTRs. Potential future …
moderate COVID-19 and post-exposure prophylaxis, including in SOTRs. Potential future …